| Code | 2472F | ||||||||||
| MA number | 46/0014/26-S | ||||||||||
| Product Form: | crm 1x60 g (tuba Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Laboratoires Bailleul S.A., Luxembourg | ||||||||||
| Therapeutic Class: | 46 - DERMATOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | tube Al | ||||||||||
| Route of admin.: | Cutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 17.02.2026 |
| Validity: | 17.02.2031 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Imaxema 20 mg/g + 1 mg/g krém_crm_01/2026_REG.pdf
|
| PIL: |
PIL_Imaxema 20 mg/g + 1 mg/g krém_crm_01/2026_REG.pdf
|
| Safety feature | Yes |
| Data update: | 23.02.2026 |
